The global photosensitizer drug market is expected to grow at a significant CAGR during the forecast period (2021-2027). In photodynamic therapy (PDT), photosensitizer medications or photosensitizing chemicals are utilized to treat cancer. When these compounds are exposed to a specific wavelength of light, an active form of oxygen is produced, which kills cancer cells nearby. Porphyrin derivatives, Aminolevulinic acid (ALA), chlorines, are some available porphyrin derivatives. Porphyrin derivative (PD), a first-generation photosensitizer, is effective in treating brain, lung, laryngeal, gastric, cutaneous, and esophageal carcinomas to a degree. Porfimer sodium, also known as Photofrin, is a photosensitizing compound used in PDT for the treatment of esophageal cancer and non-small cell lung cancer. Porphyrin-based second-generation photosensitizers include benzoporphyrins, texaphyrins, purpurins, naphthalocyanines, and phthalocyanines. 5-aminolevulinic acid (ALA) is another extensively used photosensitizer, which is mostly utilized for oral leukoplakia owing to the benefits of low-light dose.
A full report of Photosensitizer Drug Market is available at: https://www.omrglobal.com/industry-reports/photosensitizer-drug-market
During the forecast period, rising cancer prevalence and the burden of dermatological conditions are expected to drive the global photosensitizer drug market. Head and neck cancer accounted for roughly 4% of all cancers in the US in 2017, according to the American Society of Clinical Oncology (ASCO). According to the estimate, nearly 65,000 people will suffer from head and neck cancer. The demand for photosensitizer medications is expected to rise in the near future as a result of this. Skin infections are quite frequent, ranking fourth among the most common ailments in the world. According to the World Health Organization (WHO), skin cancer accounts for one out of every three cancers diagnosed, and one out of every five Americans will acquire skin cancer during their lifetime, according to Skin Cancer Foundation statistics. The demand for photosensitizer drugs is projected to be driven by the baby boomer group, which is susceptible to a variety of cancers and skin problems.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/photosensitizer-drug-market
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
- Competitive Landscape: Galderma S.A., Biofrontera AG, Sun Pharmaceutical Industries Ltd., and Others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Photosensitizer Drug Market Report Segmentation
By Product
- Porphyrin Derivatives (PD)
- Aminolevulinic acid (ALA)
- Others (Chlorines)
By Application
- Cancer
- Psoriasis
- Acne
- Others (Actinic Keratosis (AK))
By End-User
- Hospital
- Cosmetics & Dermatology Clinics (C&DC)
- Others (Cancer Treatment Centers (CCC))
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
